The Centre has amended the Drugs Rules, 1945, empowering State Drug Control Authorities to debar pharmaceutical companies that submit fake or misleading data while seeking approvals. The revised rules also mandate due process, including show-cause notices and a 30-day appeal mechanism.
Drug regulators have introduced stricter rules to eliminate duplicate and deceptively similar medicine brand names. The new First-to-Register policy and mandatory Sugam portal verification aim to prevent medication errors, improve patient safety and ensure unique brand names across the pharmaceutical industry.
Dr Sivaranjani Santosh faces legal notices from pharma firms over high-sugar ORS products, triggering nationwide support from doctors. Backed by Food Safety and Standards Authority of India norms, the controversy has intensified debate on misleading health claims
The police recovered PdC worth Rs.4.5 crore from the accused and arrested six persons. Palladium, which is used to make the catalyst PdC, is said to be the costliest among the four precious metals of gold, silver, platinum and palladium
During raids and seizures, the drug inspectors of TSDCA had collected random samples of life-saving drugs and sent them to the state-of-the-art drug laboratory of DCA for testing
Hyderabad: The first day of the 19th edition of BioAsia witnessed a panel discussion with deliberations on the significance of partnerships between IT and Pharma companies to digitise healthcare and to venture into the new paradigm of delivering healthcare for better patient outcomes. Industry experts emphasised that data analytics will help the healthcare fraternity understand […]
